Search results for " thrombopoietin receptor agonists"

showing 1 items of 1 documents

Second-line administration of thrombopoietin receptor agonists in immune thrombocytopenia: Italian Delphi-based consensus recommendations

2021

Introduction: In patients with primary immune thrombocytopenia (ITP), a short course of steroids is routinely given as first-line therapy. However, the response is often transient and additional therapy is usually needed. Thrombopoietin receptor agonists (TPO-RAs) are frequently used as second-line therapy, although there is little clinical guidance on the timing of their administration and on tapering/discontinuation of the drug. To provide clinical recommendations, we used the Delphi technique to obtain consensus for statements regarding administration and on tapering/discontinuation of second-line TPO-RAs among a group of Italian clinicians with expertise in management of ITP. Methods: T…

Thrombopoietin Receptor Agoniststherapybusiness.industryconsensus Delphi immune thrombocytopenia management second line therapy thrombopoietin receptor agonistsfood and beveragesconsensus; Delphi; immune thrombocytopenia; management; second line; therapy; thrombopoietin receptor agonistsHematologySettore MED/15DelphiImmune thrombocytopeniaSecond lineimmune thrombocytopeniaconsensusImmunologyconsensuMedicinethrombopoietin receptor agonistsDiseases of the blood and blood-forming organsIn patientsecond lineRC633-647.5businessmanagementOriginal Research
researchProduct